These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 29630890)

  • 1. Risk factors for explantation due to infection after sacral neuromodulation: a multicenter retrospective case-control study.
    Myer ENB; Petrikovets A; Slocum PD; Lee TG; Carter-Brooks CM; Noor N; Carlos DM; Wu E; Van Eck K; Fashokun TB; Yurteri-Kaplan L; Chen CCG
    Am J Obstet Gynecol; 2018 Jul; 219(1):78.e1-78.e9. PubMed ID: 29630890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromodulation and female pelvic disorders.
    Noblett K
    Curr Opin Urol; 2016 Jul; 26(4):321-7. PubMed ID: 27070647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.
    Adelstein SA; Lee W; Gioia K; Moskowitz D; Stamnes K; Lucioni A; Kobashi KC; Lee UJ
    Neurourol Urodyn; 2019 Aug; 38(6):1595-1601. PubMed ID: 31044466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
    Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
    Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacral neuromodulation for fecal incontinence in Latin America: initial results of a multicenter study.
    Oliveira L; Hagerman G; Torres ML; Lumi CM; Siachoque JAC; Reyes JC; Perez-Aguirre J; Sanchez-Robles JC; Guerrero-Guerrero VH; Regadas SM; Filho VG; Rosato G; Vieira E; Marzan L; Lima D; Londoño-Schimmer E; Wexner SD
    Tech Coloproctol; 2019 Jun; 23(6):545-550. PubMed ID: 31190233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged percutaneous SNM testing does not cause infection-related explanation.
    Amend B; Bedke J; Khalil M; Stenzl A; Sievert KD
    BJU Int; 2013 Mar; 111(3):485-91. PubMed ID: 22738331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Surgical Site Infection in Patients Undergoing Sacral Nerve Modulation Therapy.
    Brueseke T; Livingston B; Warda H; Osann K; Noblett K
    Female Pelvic Med Reconstr Surg; 2015; 21(4):198-204. PubMed ID: 26052646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-human implantation of a mid-field powered neurostimulator at the sacral nerve: Results from an acute study.
    van Kerrebroeck PEVA; Reekmans M; van Koeveringe GA; Yeh AJ; Fayram TA; Sharan AD; Comiter CV
    Neurourol Urodyn; 2019 Aug; 38(6):1669-1675. PubMed ID: 31107559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Sacral Nerve Stimulation Device Revision and Explantation in a Single Center, Multidisciplinary Study.
    Gevelinger MM; Sanderson DJ; Jaworski E; Doyle PJ
    Neuromodulation; 2020 Dec; 23(8):1201-1206. PubMed ID: 31697433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacral Neuromodulation: Determining Predictors of Success.
    Morgan TN; Pace N; Mohapatra A; Ren D; Kunkel G; Tennyson L; Shepherd JP; Chermansky CJ
    Urology; 2021 Jul; 153():124-128. PubMed ID: 32619594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults.
    Herbison GP; Arnold EP
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004202. PubMed ID: 19370596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statewide Success of Staged Sacral Neuromodulation for the Treatment of Urinary Complaints in California (2005-2011).
    Dobberfuhl AD; Mahal A; Dallas KB; Choi KM; Comiter CV; Elliott CS
    Female Pelvic Med Reconstr Surg; 2020 Jul; 26(7):437-442. PubMed ID: 30059438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sacral neuromodulation device biofilm differs in the absence and presence of infection, harbors antibiotic resistance genes, and is reproducible in vitro.
    Werneburg GT; Hettel D; Adler A; Mukherjee SD; Goldman HB; Rackley RR; Zillioux J; Martin SE; Gill BC; Shoskes DA; Miller AW; Vasavada SP
    Neurourol Urodyn; 2024 Sep; 43(7):1479-1490. PubMed ID: 38808686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromodulation in urology, state of the art.
    Ammirati E; Giammò A; Manassero A; Carone R
    Urologia; 2019 Nov; 86(4):177-182. PubMed ID: 31368415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacral neuromodulation for overactive bladder in women: do age and comorbidities make a difference?
    High RA; Winkelman W; Panza J; Sanderson DJ; Yuen H; Halder G; Shaver C; Bird ET; Rogers RG; Danford JM
    Int Urogynecol J; 2021 Jan; 32(1):149-157. PubMed ID: 32588075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections.
    Sohail MR; Hussain S; Le KY; Dib C; Lohse CM; Friedman PA; Hayes DL; Uslan DZ; Wilson WR; Steckelberg JM; Baddour LM;
    J Interv Card Electrophysiol; 2011 Aug; 31(2):171-83. PubMed ID: 21365264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of endograft infections following endovascular thoracic and abdominal aneurysm repair.
    Murphy EH; Szeto WY; Herdrich BJ; Jackson BM; Wang GJ; Bavaria JE; Fairman RM; Woo EY
    J Vasc Surg; 2013 Nov; 58(5):1179-85. PubMed ID: 23830947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric sacral nerve stimulator explanation due to complications or cure: a survival analysis.
    Rensing AJ; Szymanski KM; Dunn S; King S; Cain MP; Whittam BM
    J Pediatr Urol; 2019 Feb; 15(1):39.e1-39.e6. PubMed ID: 30473473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed analysis of adverse events and surgical interventions in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients.
    Noblett K; Benson K; Kreder K
    Neurourol Urodyn; 2017 Apr; 36(4):1136-1139. PubMed ID: 27491027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.